Operating ExpensesResearch and development ("R&D") expenses for the second quarter 2013 decreased 58% year-over-year to RMB0.5 million (US$89,516), or 1% of total revenue, compared with RMB1.3 million, or 3% of total revenue in the second quarter 2012. The decrease in R&D expenses was primarily attributable to decreased share-based compensation expenses of RMB0.9 million as the employee incentive plan granted in December 2009 ended its vesting period at the end of 2012.
EFuture Announces Unaudited Second Quarter 2013 Financial Results
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.